Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 335

1.

An Integrated Microfluidic Platform for Quantifying Drug Permeation across Biomimetic Vesicle Membranes.

Schaich M, Cama J, Al Nahas K, Sobota D, Sleath H, Jahnke K, Deshpande S, Dekker C, Keyser UF.

Mol Pharm. 2019 Jun 3;16(6):2494-2501. doi: 10.1021/acs.molpharmaceut.9b00086. Epub 2019 Apr 29.

PMID:
30994358
2.

Downstream Dislocation of a Ventriculo-Atrial Shunt Catheter.

Schaefer JH, du Mesnil de Rochemont R, Jahnke K.

Neurocrit Care. 2019 Jun;30(3):686-687. doi: 10.1007/s12028-019-00691-x. No abstract available.

PMID:
30788705
3.

Cytotoxic edema affecting distinct fiber tracts in ciguatera fish poisoning.

Yalachkov Y, Hildner M, Polomac N, Jahnke K, Wagner M, Baudrexel S.

Neurology. 2019 Jan 15;92(3):145-147. doi: 10.1212/WNL.0000000000006789. Epub 2018 Dec 21. No abstract available.

PMID:
30578371
4.

Introducing the New 3.5/28 Microstent Retriever for Recanalization of Distal Cerebral Arteries in Acute Stroke: Preliminary Results.

Müller-Eschner M, You SJ, Jahnke K, Kammerer S, Foerch C, Pfeilschifter W, Lauer A, Berkefeld J, Wagner M.

Cardiovasc Intervent Radiol. 2019 Jan;42(1):101-109. doi: 10.1007/s00270-018-2039-4. Epub 2018 Jul 23.

PMID:
30039501
5.

Cosmology and fundamental physics with the Euclid satellite.

Amendola L, Appleby S, Avgoustidis A, Bacon D, Baker T, Baldi M, Bartolo N, Blanchard A, Bonvin C, Borgani S, Branchini E, Burrage C, Camera S, Carbone C, Casarini L, Cropper M, de Rham C, Dietrich JP, Di Porto C, Durrer R, Ealet A, Ferreira PG, Finelli F, García-Bellido J, Giannantonio T, Guzzo L, Heavens A, Heisenberg L, Heymans C, Hoekstra H, Hollenstein L, Holmes R, Hwang Z, Jahnke K, Kitching TD, Koivisto T, Kunz M, La Vacca G, Linder E, March M, Marra V, Martins C, Majerotto E, Markovic D, Marsh D, Marulli F, Massey R, Mellier Y, Montanari F, Mota DF, Nunes NJ, Percival W, Pettorino V, Porciani C, Quercellini C, Read J, Rinaldi M, Sapone D, Sawicki I, Scaramella R, Skordis C, Simpson F, Taylor A, Thomas S, Trotta R, Verde L, Vernizzi F, Vollmer A, Wang Y, Weller J, Zlosnik T; Euclid Theory Working Group.

Living Rev Relativ. 2018;21(1):2. doi: 10.1007/s41114-017-0010-3. Epub 2018 Apr 12. Review.

6.

Breastfeeding friendly pharmacies: a setting with potential.

Llewellyn R, Berger S, Carty S, Randall P, Jahnke K, Thompson L.

Aust N Z J Public Health. 2017 Jun;41(3):322-323. doi: 10.1111/1753-6405.12633. Epub 2017 Jan 22. No abstract available.

PMID:
28110497
7.

Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.

Kortland LM, Alfter A, Bähr O, Carl B, Dodel R, Freiman TM, Hubert K, Jahnke K, Knake S, von Podewils F, Reese JP, Runge U, Senft C, Steinmetz H, Rosenow F, Strzelczyk A.

Epilepsia. 2016 Dec;57(12):2056-2066. doi: 10.1111/epi.13584. Epub 2016 Oct 18.

8.

[Crew resource management and simulator training in acute stroke therapy].

Tahtali D, Bohmann F, Rostek P, Misselwitz B, Reihs A, Heringer F, Jahnke K, Steinmetz H, Pfeilschifter W.

Nervenarzt. 2016 Dec;87(12):1322-1331. German.

PMID:
27431675
9.

Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.

Burger MC, Zeiner PS, Jahnke K, Wagner M, Mittelbronn M, Steinbach JP.

PLoS One. 2016 Jun 2;11(6):e0155315. doi: 10.1371/journal.pone.0155315. eCollection 2016.

10.

Books on Prescription - community-based health initiative to increase access to mental health treatment: an evaluation.

Carty S, Thompson L, Berger S, Jahnke K, Llewellyn R.

Aust N Z J Public Health. 2016 Jun;40(3):276-8. doi: 10.1111/1753-6405.12507. Epub 2016 Mar 30.

PMID:
27027774
11.

[Obituary of Prof. Dr med. Klaus Jahnke].

Jahnke K.

Laryngorhinootologie. 2016 Jan;95(1):47. doi: 10.1055/s-0041-109810. Epub 2016 Jan 12. German. No abstract available.

PMID:
26756656
12.

Germanium-Vacancy Single Color Centers in Diamond.

Iwasaki T, Ishibashi F, Miyamoto Y, Doi Y, Kobayashi S, Miyazaki T, Tahara K, Jahnke KD, Rogers LJ, Naydenov B, Jelezko F, Yamasaki S, Nagamachi S, Inubushi T, Mizuochi N, Hatano M.

Sci Rep. 2015 Aug 7;5:12882. doi: 10.1038/srep12882.

13.

[Cancer screening in the elderly: Explorative mixed methods study].

Dolezil D, Haase A, Jahnke K, Thonack J, Löffler C, Schmidt CO, Chenot JF.

Z Gerontol Geriatr. 2016 Jan;49(1):44-51. doi: 10.1007/s00391-015-0920-1. Epub 2015 Jun 25. German.

PMID:
26108994
14.

Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.

Korfel A, Thiel E, Martus P, Möhle R, Griesinger F, Rauch M, Röth A, Hertenstein B, Fischer T, Hundsberger T, Mergenthaler HG, Junghanß C, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Roth P, Bamberg M, Pietsch T, Weller M.

Neurology. 2015 Mar 24;84(12):1242-8. doi: 10.1212/WNL.0000000000001395. Epub 2015 Feb 25.

15.

All-optical initialization, readout, and coherent preparation of single silicon-vacancy spins in diamond.

Rogers LJ, Jahnke KD, Metsch MH, Sipahigil A, Binder JM, Teraji T, Sumiya H, Isoya J, Lukin MD, Hemmer P, Jelezko F.

Phys Rev Lett. 2014 Dec 31;113(26):263602. Epub 2014 Dec 22.

PMID:
25615330
16.

Indistinguishable photons from separated silicon-vacancy centers in diamond.

Sipahigil A, Jahnke KD, Rogers LJ, Teraji T, Isoya J, Zibrov AS, Jelezko F, Lukin MD.

Phys Rev Lett. 2014 Sep 12;113(11):113602. Epub 2014 Sep 11.

PMID:
25259977
17.

German medical students' exposure and attitudes toward pharmaceutical promotion: a cross-sectional survey.

Jahnke K, Kremer MS, Schmidt CO, Kochen MM, Chenot JF.

GMS Z Med Ausbild. 2014 Aug 15;31(3):Doc32. doi: 10.3205/zma000924. eCollection 2014.

18.

Multiple intrinsically identical single-photon emitters in the solid state.

Rogers LJ, Jahnke KD, Teraji T, Marseglia L, Müller C, Naydenov B, Schauffert H, Kranz C, Isoya J, McGuinness LP, Jelezko F.

Nat Commun. 2014 Aug 27;5:4739. doi: 10.1038/ncomms5739.

PMID:
25162729
19.

Corrigendum to "Automatic sleep staging using fMRI functional connectivity data" [Neuroimage 63/1 (2012) 63-72].

Tagliazucchi E, von Wegner F, Morzelewski A, Borisov S, Jahnke K, Laufs H.

Neuroimage. 2013 Nov 1;81:506. doi: 10.1016/j.neuroimage.2013.05.048. Epub 2013 May 23. No abstract available.

PMID:
30180376
20.

Breakdown of long-range temporal dependence in default mode and attention networks during deep sleep.

Tagliazucchi E, von Wegner F, Morzelewski A, Brodbeck V, Jahnke K, Laufs H.

Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15419-24. doi: 10.1073/pnas.1312848110. Epub 2013 Sep 3.

21.

Is there a metabolic requirement for photorespiratory enzyme activities in heterotrophic tissues?

Nunes-Nesi A, Florian A, Howden A, Jahnke K, Timm S, Bauwe H, Sweetlove L, Fernie AR.

Mol Plant. 2014 Jan;7(1):248-51. doi: 10.1093/mp/sst111. Epub 2013 Aug 30. No abstract available.

22.

Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.

Doolittle ND, Korfel A, Lubow MA, Schorb E, Schlegel U, Rogowski S, Fu R, Dósa E, Illerhaus G, Kraemer DF, Muldoon LL, Calabrese P, Hedrick N, Tyson RM, Jahnke K, Maron LM, Butler RW, Neuwelt EA.

Neurology. 2013 Jul 2;81(1):84-92. doi: 10.1212/WNL.0b013e318297eeba. Epub 2013 May 17.

23.

Serine acts as a metabolic signal for the transcriptional control of photorespiration-related genes in Arabidopsis.

Timm S, Florian A, Wittmiß M, Jahnke K, Hagemann M, Fernie AR, Bauwe H.

Plant Physiol. 2013 May;162(1):379-89. doi: 10.1104/pp.113.215970. Epub 2013 Mar 7.

24.

Large-scale brain functional modularity is reflected in slow electroencephalographic rhythms across the human non-rapid eye movement sleep cycle.

Tagliazucchi E, von Wegner F, Morzelewski A, Brodbeck V, Borisov S, Jahnke K, Laufs H.

Neuroimage. 2013 Apr 15;70:327-39. doi: 10.1016/j.neuroimage.2012.12.073. Epub 2013 Jan 9.

PMID:
23313420
25.

Cosmology and Fundamental Physics with the Euclid Satellite.

Amendola L, Appleby S, Bacon D, Baker T, Baldi M, Bartolo N, Blanchard A, Bonvin C, Borgani S, Branchini E, Burrage C, Camera S, Carbone C, Casarini L, Cropper M, de Rham C, Di Porto C, Ealet A, Ferreira PG, Finelli F, García-Bellido J, Giannantonio T, Guzzo L, Heavens A, Heisenberg L, Heymans C, Hoekstra H, Hollenstein L, Holmes R, Horst O, Jahnke K, Kitching TD, Koivisto T, Kunz M, La Vacca G, March M, Majerotto E, Markovic K, Marsh D, Marulli F, Massey R, Mellier Y, Mota DF, Nunes NJ, Percival W, Pettorino V, Porciani C, Quercellini C, Read J, Rinaldi M, Sapone D, Scaramella R, Skordis C, Simpson F, Taylor A, Thomas S, Trotta R, Verde L, Vernizzi F, Vollmer A, Wang Y, Weller J, Zlosnik T; Euclid Theory Working Group.

Living Rev Relativ. 2013;16(1):6. doi: 10.12942/lrr-2013-6. Epub 2013 Sep 2. Review.

26.

Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project.

Bromberg JE, Doorduijn JK, Illerhaus G, Jahnke K, Korfel A, Fischer L, Fritsch K, Kuittinen O, Issa S, van Montfort C, van den Bent MJ.

Haematologica. 2013 May;98(5):808-13. doi: 10.3324/haematol.2012.070839. Epub 2012 Nov 9.

27.

The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study.

Langosch JM, Spiegelhalder K, Jahnke K, Feige B, Regen W, Kiemen A, Hennig J, Olbrich HM.

J Clin Psychopharmacol. 2012 Oct;32(5):661-5. doi: 10.1097/JCP.0b013e318267b586.

PMID:
22926600
28.

Automatic sleep staging using fMRI functional connectivity data.

Tagliazucchi E, von Wegner F, Morzelewski A, Borisov S, Jahnke K, Laufs H.

Neuroimage. 2012 Oct 15;63(1):63-72. doi: 10.1016/j.neuroimage.2012.06.036. Epub 2012 Jun 26. Erratum in: Neuroimage. 2013 Nov 1;81:506. Neuroimage. 2013 Nov 1;81:506.

PMID:
22743197
29.

Inhibition of aconitase by nitric oxide leads to induction of the alternative oxidase and to a shift of metabolism towards biosynthesis of amino acids.

Gupta KJ, Shah JK, Brotman Y, Jahnke K, Willmitzer L, Kaiser WM, Bauwe H, Igamberdiev AU.

J Exp Bot. 2012 Feb;63(4):1773-84. doi: 10.1093/jxb/ers053.

PMID:
22371326
30.

To wake or not to wake? The two-sided nature of the human K-complex.

Jahnke K, von Wegner F, Morzelewski A, Borisov S, Maischein M, Steinmetz H, Laufs H.

Neuroimage. 2012 Jan 16;59(2):1631-8. doi: 10.1016/j.neuroimage.2011.09.013. Epub 2011 Sep 16.

PMID:
21945697
31.

[Introduction of interdisciplinary prostate cancer centers based on the recommendations of the German Cancer Society. A cost-benefit analysis 3 years after accreditation].

Weikert S, Baumunk D, Stephan C, Cash H, Jahnke K, Steiner U, Werthemann P, Kempkensteffen C, Magheli A, Hinz S, Jagota A, Reichelt U, Busch J, Klopf C, Miller K, Schostak M.

Urologe A. 2011 Sep;50(9):1083-8. doi: 10.1007/s00120-011-2629-0. German.

PMID:
21728009
32.

Genetic aspects of familial Ménière's disease.

Arweiler-Harbeck D, Horsthemke B, Jahnke K, Hennies HC.

Otol Neurotol. 2011 Jun;32(4):695-700. doi: 10.1097/MAO.0b013e318216074a.

PMID:
21436747
33.

Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.

Jahnke K, Keilholz U, Lüftner D, Thiel E, Schmittel A.

Anticancer Res. 2011 Jan;31(1):317-23.

PMID:
21273617
34.

[How to create a self-cleaning open mastoid cavity].

Lehnerdt G, Lang S, Plester D, Jahnke K.

Laryngorhinootologie. 2011 Jan;90(1):6-8. doi: 10.1055/s-0030-1268847. Epub 2011 Jan 10. German.

PMID:
21225529
35.

The hydroxypyruvate-reducing system in Arabidopsis: multiple enzymes for the same end.

Timm S, Florian A, Jahnke K, Nunes-Nesi A, Fernie AR, Bauwe H.

Plant Physiol. 2011 Feb;155(2):694-705. doi: 10.1104/pp.110.166538. Epub 2010 Dec 23.

36.

Severe meningoencephalomyelitis due to CNS-Toxocarosis.

Singer OC, Conrad F, Jahnke K, Hattingen E, Auer H, Steinmetz H.

J Neurol. 2011 Apr;258(4):696-8. doi: 10.1007/s00415-010-5807-x. Epub 2010 Nov 5. No abstract available.

PMID:
21052709
37.

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithäuser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Weller M.

Lancet Oncol. 2010 Nov;11(11):1036-47. doi: 10.1016/S1470-2045(10)70229-1. Epub 2010 Oct 20.

PMID:
20970380
38.

Treatment options for central nervous system lymphomas in immunocompetent patients.

Jahnke K, Thiel E.

Expert Rev Neurother. 2009 Oct;9(10):1497-509. doi: 10.1586/ern.09.100.

PMID:
19831839
39.

dup(19)(q12q13.2): array-based genotype-phenotype correlation of a new possibly obesity-related syndrome.

Davidsson J, Jahnke K, Forsgren M, Collin A, Soller M.

Obesity (Silver Spring). 2010 Mar;18(3):580-7. doi: 10.1038/oby.2009.298. Epub 2009 Sep 17.

40.

Basosquamous carcinoma--a rare but aggressive skin malignancy.

Volkenstein S, Wohlschlaeger J, Liebau J, Arens A, Lehnerdt G, Jahnke K, Neumann A.

J Plast Reconstr Aesthet Surg. 2010 Mar;63(3):e304-6. doi: 10.1016/j.bjps.2009.05.058. Epub 2009 Jul 31. No abstract available.

PMID:
19647505
41.

Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.

Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, Peereboom DM, Stevens G, McGregor J, Jahnke K, Lacy CA, Hedrick NA, Shalom E, Ference S, Bell S, Sorenson L, Tyson RM, Haluska M, Neuwelt EA.

J Clin Oncol. 2009 Jul 20;27(21):3503-9. doi: 10.1200/JCO.2008.19.3789. Epub 2009 May 18.

42.

Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series.

Welz H, Pöttgen C, Abu Jawad J, Wierlemann A, Wittig A, Stüben G, Budach V, Lehnerdt G, Jahnke K, Sack H, Stuschke M.

Oncology. 2009;76(6):405-12. doi: 10.1159/000215927. Epub 2009 May 4.

PMID:
19407473
43.

Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.

Jahnke K, Muldoon LL, Varallyay CG, Lewin SJ, Brown RD, Kraemer DF, Soussain C, Neuwelt EA.

Neuro Oncol. 2009 Oct;11(5):503-13. doi: 10.1215/15228517-2008-119. Epub 2009 Jan 21.

44.

Ifosfamide or trofosfamide in patients with intraocular lymphoma.

Jahnke K, Thiel E, Bechrakis NE, Willerding G, Kraemer DF, Fischer L, Korfel A.

J Neurooncol. 2009 Jun;93(2):213-7. doi: 10.1007/s11060-008-9761-8. Epub 2008 Dec 20.

PMID:
19099202
45.

First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.

Maza S, Kiewe P, Munz DL, Korfel A, Hamm B, Jahnke K, Thiel E.

Neuro Oncol. 2009 Aug;11(4):423-9. doi: 10.1215/15228517-2008-108. Epub 2008 Dec 5.

46.

The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx.

Lehnerdt GF, Franz P, Winterhoff S, Bankfalvi A, Grehl S, Lang S, Schmid KW, Siffert W, Jahnke K, Frey UH.

Laryngoscope. 2008 Dec;118(12):2172-6. doi: 10.1097/MLG.0b013e318185793ds.

PMID:
19029852
47.

Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.

Lehnerdt GF, Franz P, Bankfalvi A, Grehl S, Jahnke K, Lang S, Schmid KW, Siffert W, Frey UH.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3203-7. doi: 10.1158/1055-9965.EPI-08-0616.

48.

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

Grimm SA, McCannel CA, Omuro AM, Ferreri AJ, Blay JY, Neuwelt EA, Siegal T, Batchelor T, Jahnke K, Shenkier TN, Hall AJ, Graus F, Herrlinger U, Schiff D, Raizer J, Rubenstein J, Laperriere N, Thiel E, Doolittle N, Iwamoto FM, Abrey LE.

Neurology. 2008 Oct 21;71(17):1355-60. doi: 10.1212/01.wnl.0000327672.04729.8c.

49.

Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.

Jahnke K, Muldoon LL, Varallyay CG, Lewin SJ, Kraemer DF, Neuwelt EA.

Neuro Oncol. 2009 Apr;11(2):142-50. doi: 10.1215/15228517-2008-077. Epub 2008 Sep 4.

50.

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma.

Fischer L, Korfel A, Kiewe P, Neumann M, Jahnke K, Thiel E.

Ann Hematol. 2009 Feb;88(2):133-9. doi: 10.1007/s00277-008-0575-8. Epub 2008 Aug 5.

PMID:
18679681

Supplemental Content

Loading ...
Support Center